Giuseppe Morelli is a Gastroenterology physician. OpenAlex indexes 77 publications with 2,249 citations (h-index 24); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-392-2877Provider last certified this registry record 4 Sept 2024.
Clinical trials
- Tolvaptan for Ascites in Cirrhotic Patients
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mirum Pharmaceuticals, Inc.Program year20257 payments
- Gilead Sciences, Inc.Program year202521 payments
- Madrigal PharmaceuticalsProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44.7%Rifamycin Antibacterial18.1%Xifaxan100%Part D≥13 patientsProton pump inhibitor13.1%Omeprazole43%Pantoprazole Sodium33%Lansoprazole25%Part D<11 patients+ 2 more classes in this area
Cardiovascular
34%Aldosterone antagonist (MRA)18.1%Spironolactone100%Part D≥24 patientsLoop diuretic12.5%Furosemide74%Bumetanide26%Part D<11 patients+ 1 more class in this area
Cancer & immunology
11%Purine Antimetabolite5.6%Azathioprine100%Part D<11 patientsCalcineurin inhibitor5.4%Tacrolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt
European Journal of Gastroenterology & Hepatology
2024 - Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era—An ALTA Group Study
The American Journal of Gastroenterology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”